Influenza in the Age of COVID-19
U.S. Pharm.
; 46:31-35, 2021.
Article
in English
| EMBASE | ID: covidwho-1866164
ABSTRACT
Very little data are available on how the coronavirus disease 2019 (COVID-19) pandemic will affect influenza, and although new information is emerging daily, much remains to be learned. Infection-control measures undertaken as a result of the COVID-19 pandemic have significantly impacted the annual influenza season, with a substantial drop in positive influenza cases compared with previous years. Despite the lack of influenza circulation, data suggest that coinfection with influaenza and severe acute respiratory syndrome coronavirus 2 worsens disease severity and worsens prognosis. Although the spread of influenza decreased, misinformation has widely increased. Pharmacists have proven to be essential in the community, offering support not only in vaccine administration and point-of-care testing but also in combating misinformation through education.
ad26.cov2.s vaccine; baloxavir marboxil; baricitinib; biontech pfizer covid19 vaccine; covid19 vaccine johnson and johnson; dexamethasone; elasomeran; moderna covid19 vaccine; oseltamivir; peramivir; remdesivir; tozinameran; zanamivir; article; coronavirus disease 2019; disease severity; human; infection control; influenza; nonhuman; pandemic; point of care testing; prognosis; season; Severe acute respiratory syndrome coronavirus 2
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
U.S. Pharm.
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS